Abuse-Deterrent Opioid Formulations #329.
作者信息
O'Neill Ryann, Lor Kimberly, Pruskowski Jennifer
出版信息
J Palliat Med. 2017 Jun;20(6):676-678. doi: 10.1089/jpm.2017.0088. Epub 2017 Mar 23.
PMID:28333577
Abstract
摘要
相似文献
1
Abuse-Deterrent Opioid Formulations #329.阿片类药物滥用威慑制剂#329
J Palliat Med. 2017 Jun;20(6):676-678. doi: 10.1089/jpm.2017.0088. Epub 2017 Mar 23.
2
Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 Testing.基于实验室的测试，用于评估防滥用制剂并满足美国食品药品监督管理局对1类测试的建议。
J Opioid Manag. 2017 Nov/Dec;13(6):441-448. doi: 10.5055/jom.2017.0420.
3
Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?滥用防范阿片类药物制剂：预防阿片灾难的关键因素？
Clin Drug Investig. 2018 Jul;38(7):573-577. doi: 10.1007/s40261-018-0651-3.
4
Abuse-deterrent opioids: an update on current approaches and considerations.阿片类药物滥用威慑：当前方法与考量的最新进展
Curr Med Res Opin. 2018 Apr;34(4):711-723. doi: 10.1080/03007995.2017.1419171. Epub 2018 Jan 10.
5
Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.美国缓释、抗滥用阿片类药物制剂的现状与未来发展
Postgrad Med. 2017 Jan;129(1):102-110. doi: 10.1080/00325481.2017.1268902. Epub 2016 Dec 12.
6
Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.处方阿片类镇痛药的滥用途径：对滥用威慑剂型潜在影响的综述与评估
Postgrad Med. 2016 Jan;128(1):85-96. doi: 10.1080/00325481.2016.1120642. Epub 2015 Dec 18.
7
Safety and performance of current abuse-deterrent formulations.现行防滥用配方的安全性和性能。
Expert Opin Drug Metab Toxicol. 2018 Dec;14(12):1255-1271. doi: 10.1080/17425255.2018.1546289. Epub 2018 Dec 2.
8
Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.用于慢性非癌性疼痛管理的处方阿片类镇痛药的抗滥用制剂。
Pain Manag. 2016 Oct;6(5):497-508. doi: 10.2217/pmt-2015-0005. Epub 2016 Apr 6.
9
Regulatory and evidence-based considerations for abuse-deterrent opioids.滥用威慑型阿片类药物的监管及循证考量
Am J Health Syst Pharm. 2019 Jan 16;76(2):114-118. doi: 10.1093/ajhp/zxy013.
10
ADF: Abuse-Deterrent Formulation or Another Disillusioned Formulation?
Pain Med. 2018 May 1;19(5):907-909. doi: 10.1093/pm/pnx232.
Zotero 插件